Tadatsugu Taniguchi Selected Research

Transcription Factors (Transcription Factor)

1/2021	Genetic and chemical inhibition of IRF5 suppresses pre-existing mouse lupus-like disease.
1/2016	Lyn Kinase Suppresses the Transcriptional Activity of IRF5 in the TLR-MyD88 Pathway to Restrain the Development of Autoimmunity.
12/2015	Multifaceted contribution of the TLR4-activated IRF5 transcription factor in systemic sclerosis.
8/2014	Recognition of tumor cells by Dectin-1 orchestrates innate immune cells for anti-tumor responses.
11/2012	The IRF family of transcription factors: Inception, impact and implications in oncogenesis.
4/2010	Regulation of immunity and oncogenesis by the IRF transcription factor family.
3/2008	Interferon regulatory factor family of transcription factors and regulation of oncogenesis.
2/2008	A cell-type-specific requirement for IFN regulatory factor 5 (IRF5) in Fas-induced apoptosis.
1/2008	The IRF family transcription factors in immunity and oncogenesis.
2/2007	Role of IFN regulatory factor 5 transcription factor in antiviral immunity and tumor suppression.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tadatsugu Taniguchi Research Topics

Disease

13	Neoplasms (Cancer) 11/2021 - 11/2006
11	Infections 07/2021 - 08/2004
11	Virus Diseases (Viral Diseases) 08/2015 - 05/2003
6	Inflammation (Inflammations) 01/2021 - 12/2005
6	Carcinogenesis 03/2016 - 11/2006
4	Colitis 01/2017 - 01/2011
3	Septic Shock (Toxic Shock Syndrome) 01/2018 - 07/2003
3	Bacterial Infections (Bacterial Infection) 12/2013 - 08/2004
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2021 - 01/2016
2	Autoimmune Diseases (Autoimmune Disease) 01/2021 - 01/2016
2	Bites and Stings (Sting) 09/2018 - 12/2014
2	Neoplasm Metastasis (Metastasis) 04/2017 - 12/2016
2	Stomach Neoplasms (Stomach Cancer) 03/2016 - 03/2009
2	Hypersensitivity (Allergy) 01/2011 - 11/2005
2	Bone Diseases (Bone Disease) 01/2009 - 12/2005
2	Bone Resorption 12/2005 - 02/2005
2	Shock 11/2005 - 03/2005
1	Hepatitis 09/2021
1	Porcine Reproductive and Respiratory Syndrome (PRRS) 07/2021
1	Allergic Contact Dermatitis 01/2021
1	Sepsis (Septicemia) 01/2018
1	Ascites 04/2017
1	Dysbiosis 01/2017
1	Chronic Hepatitis B 01/2017
1	Disease Susceptibility (Diathesis) 12/2015
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 12/2015
1	Systemic Scleroderma (Systemic Sclerosis) 12/2015
1	Endotoxemia 12/2013
1	Heart Failure 05/2011
1	Hypertrophy 05/2011
1	Fibrosis (Cirrhosis) 05/2011
1	Hypertension (High Blood Pressure) 05/2011
1	Condylomata Acuminata (Genital Wart) 08/2009
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 08/2009
1	Papilloma (Papillomatosis) 08/2009
1	Recurrent respiratory papillomatosis 08/2009
1	Osteoporosis 01/2009
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 12/2008
1	Necrosis 03/2005

Drug/Important Bio-Agent (IBA)

11	Transcription Factors (Transcription Factor)IBA 01/2021 - 03/2005
10	CytokinesIBA 09/2021 - 05/2003
7	InterferonsIBA 09/2018 - 03/2007
6	Toll-Like Receptors (Toll-Like Receptor)IBA 11/2021 - 02/2004
6	Proteins (Proteins, Gene)FDA Link 01/2021 - 04/2004
6	Interferon Type IIBA 09/2018 - 08/2004
5	DNA (Deoxyribonucleic Acid)IBA 09/2018 - 03/2005
5	Antiviral Agents (Antivirals)IBA 01/2017 - 04/2005
4	LipopolysaccharidesIBA 01/2018 - 07/2003
3	HMGB1 Protein (HMG1)IBA 01/2021 - 12/2012
3	Factor V (Coagulation Factor V)IBA 12/2015 - 02/2007
2	Pattern Recognition ReceptorsIBA 07/2021 - 07/2011
2	Interferon-betaIBA 01/2017 - 07/2003
2	Dextran SulfateIBA 01/2017 - 12/2012
2	Dinoprostone (PGE2)FDA Link 04/2016 - 03/2016
2	A-Form DNA (A-DNA)IBA 12/2013 - 10/2009
2	Nucleic AcidsIBA 07/2011 - 12/2008
2	Toll-Like Receptor 9IBA 07/2007 - 04/2005
1	Concanavalin AIBA 09/2021
1	Small Interfering RNA (siRNA)IBA 09/2021
1	Antigen Receptors (Antigen Receptor)IBA 07/2021
1	Immunologic Factors (Immunomodulators)IBA 01/2021
1	Translationally-Controlled 1 Tumor ProteinIBA 01/2021
1	Pathogen-Associated Molecular Pattern MoleculesIBA 11/2019
1	picolinamideIBA 09/2018
1	Pharmaceutical PreparationsIBA 09/2018
1	Indicators and Reagents (Reagents)IBA 09/2018
1	GlucocorticoidsIBA 01/2017
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2017
1	Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)IBA 01/2017
1	C-Type Lectins (C-Type Lectin)IBA 12/2016
1	mouse dectin-2IBA 12/2016
1	LipidsIBA 04/2016
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 04/2016
1	Acetaminophen (Paracetamol)FDA LinkGeneric 04/2016
1	Myeloid Differentiation Factor 88IBA 03/2016
1	Bleomycin (Blenoxane)FDA LinkGeneric 12/2015
1	Mitochondrial DNA (mtDNA)IBA 12/2014
1	dectin 1IBA 08/2014
1	Polysaccharides (Glycans)IBA 08/2014
1	Carrier Proteins (Binding Protein)IBA 12/2013
1	Thymic Stromal LymphopoietinIBA 12/2012
1	HMGB ProteinsIBA 12/2012
1	InterleukinsIBA 05/2012
1	RNA (Ribonucleic Acid)IBA 07/2011
1	Angiotensin IIIBA 05/2011
1	Interferon Regulatory Factor-3 (Interferon Regulatory Factor 3)IBA 05/2011
1	Immunoglobulin E (IgE)IBA 01/2011
1	Messenger RNA (mRNA)IBA 03/2009
1	hydroxide ionIBA 01/2009
1	Toll-Like Receptor 3IBA 12/2008
1	Interferon Regulatory FactorsIBA 03/2008
1	Interferon LambdaIBA 03/2007
1	RANK LigandIBA 12/2005
1	Interleukin-6 (Interleukin 6)IBA 03/2005
1	Interleukin-12 (IL 12)IBA 03/2005
1	LigandsIBA 02/2005
1	Receptor Activator of Nuclear Factor-kappa B (TRANCE-R)IBA 02/2005

Therapy/Procedure

8	Therapeutics 01/2021 - 01/2009
3	Immunotherapy 11/2021 - 01/2021
1	Oral Administration 08/2013